NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









DNA Script

DNA Script

Private
ParisHealthcare & Life Scienceshttps://www.dnascript.com/

Last Round

Series C

Jan 4, 2022

Total Funding Raised

$613.55M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

DNA Script is a biotechnology company that develops enzymatic DNA synthesis technology and benchtop DNA printers for the rapid, on-demand production of synthetic nucleic acids.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, 3D Printing, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS, Government Contracts

AI Layer

Non-AI

Keywords

enzymatic DNA synthesisEDSbenchtop DNA printerDNA printingsynthetic biologyoligo synthesison-demand DNAbiotech hardwaremolecular biology toolslab automationrazor-and-blades modelbiomanufacturingDNA reagentsdesktop biotechdecentralized manufacturing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

DNA Script Comps

Public and private peers based on sector, stage, and business model.

DNA Script comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

DNA Script Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CJan 4, 2022
Series COct 26, 2021
GrantApr 27, 2021
GrantMar 2, 2021
Series BJul 29, 2020
Series B
May 16, 2019

Key People

Founding team and executive leadership

Xavier Godron

Co-founder CTO

Founding Team

Marc Montserrat

Chief Executive Officer

Executive Team

DNA Script Investors

Notable investors and investment history

DNA Script investors
InvestorRounds
Farallon Capital ManagementSeries C
EQT Life SciencesSeries C, Series B
Columbia Threadneedle InvestmentsSeries C
Idinvest PartnersSeed, Series B, Series A
European CommissionGrant
M VenturesSeries C, Series B, Series A
Columbia Threadneedle InvestmentsSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 17, 2026

    Agreement signed with BioStream Co. for South Korea distribution.

  • Mar 17, 2026

    Partnered with Bio-Medical Science Co. to expand SYNTAX platform access in Japan.

DNA Script Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

DNA Script Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about DNA Script's valuation, stock price, and market status.

Firmographic Details

HeadquartersParis
Employee Range132
Year Founded2014
Last FundingJan 4, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.